From the Guidelines
Perimenopause diagnosis is primarily based on clinical symptoms, and laboratory tests such as follicle-stimulating hormone (FSH), estradiol, thyroid-stimulating hormone (TSH), and complete blood count (CBC) serve as supportive information rather than definitive diagnostic criteria. The diagnosis of perimenopause is often guided by symptoms rather than lab values, as hormone levels can fluctuate significantly during this transitional phase. Some key points to consider when evaluating laboratory tests for perimenopause diagnosis include:
- FSH levels above 30 mIU/mL may suggest declining ovarian function, but a single measurement is not definitive due to fluctuating levels during perimenopause 1.
- Testing should be done on day 2-5 of the menstrual cycle when possible.
- Additional tests such as lipid panels, blood glucose, and vitamin D levels may be considered to assess overall health during this transition.
- Symptoms such as hot flashes, night sweats, or mood changes may prompt testing even with regular periods.
- Repeat testing may be necessary as hormone levels fluctuate significantly during this transitional phase, which typically lasts 4-8 years before menopause. It's essential to note that the provided study 1 focuses on anti-müllerian hormone (AMH) in polycystic ovary syndrome (PCOS) and does not directly address perimenopause diagnosis. However, it highlights the importance of considering the limitations and variability of hormone level measurements in different contexts. In the context of perimenopause, the clinical symptoms and overall health assessment play a more significant role in diagnosis and treatment decisions than laboratory tests alone.